References

Altman, Douglas G, and J Martin Bland. 2007. “Missing Data.” BMJ 334 (7590): 424–24. https://doi.org/10.1136/bmj.38977.682025.2c.

Betensky, Rebecca A. 2015. “Measures of Follow-up in Time-to-Event Studies: Why Provide Them and What Should They Be?” Clinical Trials 12 (4): 403–8. https://doi.org/10.1177/1740774515586176.

Brenner, Hermann, and Olaf Gefeller. 1997. “VARIATION OF SENSITIVITY, SPECIFICITY, LIKELIHOOD RATIOS AND PREDICTIVE VALUES WITH DISEASE PREVALENCE.” Statistics in Medicine 16 (9): 981–91. https://doi.org/10.1002/(sici)1097-0258(19970515)16:9<981::aid-sim510>3.0.co;2-n.

Clark, T G, M J Bradburn, S B Love, and D G Altman. 2003. “Survival Analysis Part I: Basic Concepts and First Analyses.” British Journal of Cancer 89 (2): 232–38. https://doi.org/10.1038/sj.bjc.6601118.

Croxton, Frederick E., and Dudley J. Cowden. 1939. Applied General Statistics. Prentice-Hall, Inc. https://doi.org/10.1037/13608-000.

Engler, Jan Broder. 2025. “Tidyplots Empowers Life Scientists with Easy Code-Based Data Visualization.” iMeta, March. https://doi.org/10.1002/imt2.70018.

Finetti, Bruno de, Maria Carla Galavotti, Hykel Hosni, and Alberto Mura. 2008. “Introductory Lecture.” In, 1–14. Springer Netherlands. https://doi.org/10.1007/978-1-4020-8202-3_1.

Gehan, E. A. 1965. “A Generalized Wilcoxon Test for Comparing Arbitrarily Singly-Censored Samples.” Biometrika 52 (1-2): 203–24. https://doi.org/10.1093/biomet/52.1-2.203.

Grambsch, Terry M., Patricia M. And Therneau. 1994. “Proportional Hazards Tests and Diagnostics Based on Weighted Residuals.” Biometrika 81 (3): 515–26. https://doi.org/10.1093/biomet/81.3.515.

Greenwood, Major. 1926. A Report on the Natural Duration of Cancer. H.M. Stationery Office.

Harrington, David P., and Thomas R. Fleming. 1982. “A Class of Rank Test Procedures for Censored Survival Data.” Biometrika 69 (3): 553–66. https://doi.org/10.1093/biomet/69.3.553.

Heymans, Martijn W., and Jos W. R. Twisk. 2022. “Handling Missing Data in Clinical Research.” Journal of Clinical Epidemiology 151 (November): 185–88. https://doi.org/10.1016/j.jclinepi.2022.08.016.

Hippel, Paul T. von. 2005. “Mean, Median, and Skew: Correcting a Textbook Rule.” Journal of Statistics Education 13 (2). https://doi.org/10.1080/10691898.2005.11910556.

Hosmer, David W., Stanley Lemeshow, and Susanne May. 2008. “Applied Survival Analysis.” Wiley Series in Probability and Statistics, February. https://doi.org/10.1002/9780470258019.

Kaplan, E. L., and Paul Meier. 1958. “Nonparametric Estimation from Incomplete Observations.” Journal of the American Statistical Association 53 (282): 457–81. https://doi.org/10.1080/01621459.1958.10501452.

Korn, Edward L. 1986. “Censoring Distributions as a Measure of Follow-up in Survival Analysis.” Statistics in Medicine 5 (3): 255–60. https://doi.org/10.1002/sim.4780050306.

Leeflang, Mariska M. G., Anne W. S. Rutjes, Johannes B. Reitsma, Lotty Hooft, and Patrick M. M. Bossuyt. 2013. “Variation of a Test’s Sensitivity and Specificity with Disease Prevalence.” Canadian Medical Association Journal 185 (11): E537–44. https://doi.org/10.1503/cmaj.121286.

Lesan, Vadim, Timothée Olivier, and Vinay Prasad. 2024. “Progression-Free Survival Estimates Are Shaped by Specific Censoring Rules: Implications for PFS as an Endpoint in Cancer Randomized Trials.” European Journal of Cancer 202 (May): 114022. https://doi.org/10.1016/j.ejca.2024.114022.

Li, J., and J. P. Fine. 2011. “Assessing the Dependence of Sensitivity and Specificity on Prevalence in Meta-Analysis.” Biostatistics 12 (4): 710–22. https://doi.org/10.1093/biostatistics/kxr008.

Mantel, Nathan. 1963. “Chi-Square Tests with One Degree of Freedom; Extensions of the Mantel- Haenszel Procedure.” Journal of the American Statistical Association 58 (303): 690. https://doi.org/10.2307/2282717.

Mantel, Nathan, and William Haenszel. 1959. “Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease.” JNCI: Journal of the National Cancer Institute, April. https://doi.org/10.1093/jnci/22.4.719.

Morris, Tim P, Christopher I Jarvis, William Cragg, Patrick P J Phillips, Babak Choodari-Oskooei, and Matthew R Sydes. 2019. “Proposals on KaplanMeier Plots in Medical Research and a Survey of Stakeholder Views: KMunicate.” BMJ Open 9 (9): e030215. https://doi.org/10.1136/bmjopen-2019-030215.

Msaouel, Pavlos. 2024. “Decoding Randomized Controlled Trials: An Information Science Perspective.” Issue 6.2, Spring 2024 6 (2). https://doi.org/10.1162/99608f92.49e3c961.

Murad, M. Hassan, Lifeng Lin, Haitao Chu, Bashar Hasan, Reem A. Alsibai, Alzhraa S. Abbas, Reem A. Mustafa, and Zhen Wang. 2023. “The Association of Sensitivity and Specificity with Disease Prevalence: Analysis of 6909 Studies of Diagnostic Test Accuracy.” Canadian Medical Association Journal 195 (27): E925–31. https://doi.org/10.1503/cmaj.221802.

Peto, Richard, and Julian Peto. 1972. “Asymptotically Efficient Rank Invariant Test Procedures.” Journal of the Royal Statistical Society. Series A (General) 135 (2): 185. https://doi.org/10.2307/2344317.

Rosen, Kate, Vinay Prasad, and Emerson Y. Chen. 2020. “Censored Patients in KaplanMeier Plots of Cancer Drugs: An Empirical Analysis of Data Sharing.” European Journal of Cancer 141 (December): 152–61. https://doi.org/10.1016/j.ejca.2020.09.031.

Schemper, Michael, and Terry L. Smith. 1996. “A Note on Quantifying Follow-up in Studies of Failure Time.” Controlled Clinical Trials 17 (4): 343–46. https://doi.org/10.1016/0197-2456(96)00075-x.

Schoenfeld, David. 1982. “Partial Residuals for the Proportional Hazards Regression Model.” Biometrika 69 (1): 239–41. https://doi.org/10.1093/biomet/69.1.239.

Templeton, Arnoud J., Olga Ace, Eitan Amir, Francisco Vera-Badillo, Alberto Ocana, Gregory R. Pond, and Ian F. Tannock. 2015. “Influence of Censoring on Conclusions of Trials for Women with Metastatic Breast Cancer.” European Journal of Cancer 51 (6): 721–24. https://doi.org/10.1016/j.ejca.2014.12.016.

Thabane, Lehana, Lawrence Mbuagbaw, Shiyuan Zhang, Zainab Samaan, Maura Marcucci, Chenglin Ye, Marroon Thabane, et al. 2013. “A Tutorial on Sensitivity Analyses in Clinical Trials: The What, Why, When and How.” BMC Medical Research Methodology 13 (1). https://doi.org/10.1186/1471-2288-13-92.

Uy, Elenore Judy B. 2022. “Key Concepts in Clinical Epidemiology: Estimating Pre-Test Probability.” Journal of Clinical Epidemiology 144 (April): 198–202. https://doi.org/10.1016/j.jclinepi.2021.10.022.